Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Nutr Rev ; 82(3): 407-424, 2024 Feb 12.
Article in English | MEDLINE | ID: mdl-37349898

ABSTRACT

Brazil has great biodiversity, and the Amazon biome stands out for a variety of native fruits with high economic and nutritional potential. Murici (Byrsonima crassifolia) and taperebá (Spondias mombin) are sources of vitamins, minerals, and phytochemicals with potential health benefits. Because of the bioactive potential of these Brazilian fruits, this review aims to gather the most current existing knowledge about their botanical, nutritional, and phytochemical properties, because the presence of several bioactive compounds may bring promising strategies to the prevention and treatment of several diseases. The search was conducted of the LILACS, MEDLINE, PubMed, and Science Direct databases, considering articles published between 2010 and 2023. The compiled results showed that these fruits, their leaves, and seeds have great antioxidant activity and are a good source of phytochemicals, especially phenolic compounds. In vitro and in vivo studies indicate that these bioactive compounds have several health benefits related to the prevention or treatment of diseases, including antioxidant effects; anti-inflammatory effects; and antidiabetic, antidepressant, neuroprotective, antiproliferative, anticancer, hypolipemic, cardioprotective, gastroprotective, hepatoprotective, and nephroprotective effects, and they are particularly related to the reduction of damage from oxidative stress. This review highlights the potential of these fruits as functional foods and for therapeutic purposes. However, it is recommended to conduct more studies on the identification and quantification of phytochemicals present in these fruits and studies in humans to better understand the mechanisms of action related to their effects and to understand the interaction of these compounds with the human body, as well as to prove the safety and efficacy of these compounds on health.


Subject(s)
Anacardiaceae , Antioxidants , Animals , Humans , Antioxidants/pharmacology , Antioxidants/analysis , Phytochemicals/pharmacology , Phytochemicals/analysis , Anacardiaceae/chemistry , Fruit/chemistry , Cell Culture Techniques
2.
Eur J Nutr ; 57(5): 1829-1844, 2018 Aug.
Article in English | MEDLINE | ID: mdl-28501921

ABSTRACT

PURPOSE: Obese individuals have higher production of reactive oxygen species, which leads to oxidative damage. We hypothesize that cranberry extract (CE) can improve this dysfunction in HFD-induced obesity in rats since it has an important antioxidant activity. Here, we evaluated the effects of CE in food intake, adiposity, biochemical and hormonal parameters, lipogenic and adipogenic factors, hepatic morphology and oxidative balance in a HFD model. METHODS: At postnatal day 120 (PN120), male Wistar rats were assigned into two groups: (1) SD (n = 36) fed with a standard diet and (2) HFD (n = 36), fed with a diet containing 44.5% (35.2% from lard) energy from fat. At PN150, 12 animals from SD and HFD groups were killed while the others were subdivided into four groups (n = 12/group): animals that received 200 mg/kg cranberry extract (SD CE, HFD CE) gavage/daily/30 days or water (SD, HFD). At PN180, animals were killed. RESULTS: HFD group showed higher body mass and visceral fat, hypercorticosteronemia, higher liver glucocorticoid sensitivity, cholesterol and triglyceride contents and microsteatosis. Also, HFD group had higher lipid peroxidation (plasma and tissues) and higher protein carbonylation (liver and adipose tissue) compared to SD group. HFD CE group showed lower body mass gain, hypotrygliceridemia, hypocorticosteronemia, and lower hepatic cholesterol and fatty acid synthase contents. HFD CE group displayed lower lipid peroxidation, protein carbonylation (liver and adipose tissue) and accumulation of liver fat compared to HFD group. CONCLUSION: Although adiposity was not completely reversed, cranberry extract improved the metabolic profile and reduced oxidative damage and steatosis in HFD-fed rats, which suggests that it can help manage obesity-related disorders.


Subject(s)
Diet, High-Fat , Lipid Metabolism/drug effects , Liver/metabolism , Obesity/drug therapy , Plant Extracts/pharmacology , Vaccinium macrocarpon/chemistry , Animals , Brazil , Cholesterol/metabolism , Fatty Liver , Male , Mice , Plant Extracts/administration & dosage , Rats , Rats, Wistar
3.
Acta Vet Scand ; 57: 34, 2015 Jun 24.
Article in English | MEDLINE | ID: mdl-26104069

ABSTRACT

BACKGROUND: Surgery is the treatment of choice for regional control of mammary neoplasms in female dogs. Various surgical techniques may be used, as long as mammary gland anatomy, lymphatic drainage, and known prognostic factors are respected. The purpose of this study was to compare surgical stress-including duration of surgery, nociception and hematological changes-and postoperative complications in dogs undergoing regional and unilateral radical mastectomy. Eighteen dogs were selected for each technique. Postoperative pain (nociception), hematological changes, and postoperative complications were compared between the two groups. RESULTS: The group treated with radical mastectomy had a longer surgical duration, showed more intense physiological changes, achieved higher scores on nociception scales, and experienced more postoperative complications. CONCLUSION: Compared to regional mastectomy, radical mastectomy was associated with longer surgical duration, greater nociceptive stimulus, greater surgical stress, and higher incidence of postoperative complications in dogs. Although evaluation of long-term results was not a goal of this study, it is suggested that postoperative recovery and patient quality of life should be considered when choosing a surgical approach for treating mammary tumors in dogs.


Subject(s)
Dog Diseases/surgery , Mammary Neoplasms, Animal/surgery , Mastectomy/veterinary , Postoperative Complications/veterinary , Animals , Blood Chemical Analysis/veterinary , Dogs , Female , Hematologic Tests/veterinary , Mastectomy/adverse effects , Mastectomy, Radical/adverse effects , Mastectomy, Radical/veterinary , Nociception , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Stress, Physiological , Time Factors
4.
Cell Rep ; 7(4): 1093-103, 2014 May 22.
Article in English | MEDLINE | ID: mdl-24813890

ABSTRACT

Leptin has beneficial effects on glucose metabolism via actions in the hypothalamus, but the roles of specific subgroups of neurons responsible for these antidiabetic effects remain unresolved. We generated diabetic Lep(ob/ob) or Lepr(db/db) mice lacking or re-expressing leptin receptors (LepRb) in subgroups of neurons to explore their contributions to leptin's glucose-lowering actions. We show that agouti-related peptide (AgRP)-expressing neurons are both required and sufficient to correct hyperglycemia by leptin. LepRb in pro-opiomelanocortin (POMC) neurons or steroidogenic factor-1 (SF1) neurons are not required. Furthermore, normalization of blood glucose by leptin is blunted in Lep(ob/ob)/MC4R-null mice, but not in Lep(ob/ob) mice lacking neuropeptide Y (NPY) or gamma-aminobutyric acid (GABA) in AgRP neurons. Leptin's ability to improve glucose balance is accompanied by a reduction in circulating glucagon. We conclude that AgRP neurons play a crucial role in glucose-lowering actions by leptin and that this requires the melanocortin system, but not NPY and GABA.


Subject(s)
Agouti-Related Protein/metabolism , Diabetes Mellitus, Experimental/prevention & control , Hypothalamus/metabolism , Leptin/metabolism , Melanocortins/metabolism , Neurons/metabolism , Receptors, Leptin/metabolism , Animals , Blood Glucose/metabolism , Diabetes Mellitus, Experimental/metabolism , Female , Glucagon/metabolism , Humans , Hypothalamus/cytology , Leptin/pharmacology , Male , Mice , Mice, Transgenic , Neurons/cytology
5.
Can Vet J ; 52(1): 77-9, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21461213

ABSTRACT

Cardiorespiratory and blood gas alterations were evaluated in 6 healthy dogs that underwent a laparoscopic procedure using isoflurane anesthesia and carbon dioxide (CO(2)) pneumoperitoneum for 30 min. Heart rate, respiratory rate, body temperature, venous blood pH, partial pressure of CO(2) and oxygen, oxygen saturation, total carbon dioxide (TCO(2)) and bicarbonate were monitored. Significant alterations were hypercapnia, hypoventilation, and respiratory acidosis.


Subject(s)
Blood Gas Analysis/veterinary , Dogs/physiology , Heart Rate/physiology , Insemination, Artificial/veterinary , Animals , Bicarbonates/blood , Blood Pressure/physiology , Body Temperature/physiology , Carbon Dioxide/blood , Female , Hemodynamics , Hydrogen-Ion Concentration , Insemination, Artificial/physiology , Oxygen/blood
6.
Acta Vet Scand ; 52: 67, 2010 Dec 22.
Article in English | MEDLINE | ID: mdl-21176231

ABSTRACT

BACKGROUND: Mammary tumors are among the most frequent neoplasms in female dogs, but the strategies employed in animal treatment are limited. In human medicine, hormone manipulation is used in cancer therapy. Tamoxifen citrate is a selective inhibitor of oestrogen receptors and exerts a potent anti-oestrogen effect on the mammary gland. The aim of this study was to evaluate the adverse effects when exposing healthy female dogs to tamoxifen. METHODS: Tamoxifen was administered for 120 days at a dose of 0.5 or 0.8 mg/kg/day to either intact or spayed female dogs. The effects were assessed through clinical examination, haematology, serum biochemistry, ophthalmology and bone marrow aspirate examination. Ovariohysterectomy was performed and the uterus examined by histopathology. RESULTS: Vulva oedema and purulent vaginal discharge developed with 10 days of tamoxifen exposure in all groups. Pyometra was diagnosed after around 90 days of exposure in intact females with frequencies increasing during the following 30 days of exposure. Up to 50% of dogs within the groups developed retinitis but none of the dogs had signs of reduced visual acuity. The prevalence of retinitis in each group was similar after 120 days of exposure. Haematological, biochemical and bone marrow changes were not observed. Due to the high risk of developing pyometra after prolonged exposure to tamoxifen, only spayed animals should be given this medication. CONCLUSIONS: A dose of 0.8 mg tamoxifen/kg body weight/day is recommended when treating tamoxifen-responsive canine mammary tumors. Due to the high risk of developing pyometra, ovariohysterectomy is recommended.


Subject(s)
Antineoplastic Agents, Hormonal/adverse effects , Dog Diseases/chemically induced , Tamoxifen/adverse effects , Animals , Antineoplastic Agents, Hormonal/administration & dosage , Dogs , Dose-Response Relationship, Drug , Edema/chemically induced , Edema/veterinary , Female , Hysterectomy/veterinary , Pyometra/chemically induced , Pyometra/veterinary , Retinitis/chemically induced , Retinitis/veterinary , Tamoxifen/administration & dosage , Vulvar Diseases/chemically induced , Vulvar Diseases/veterinary
SELECTION OF CITATIONS
SEARCH DETAIL
...